Haohai Biological Says Preliminary Figures Show Drop in 2025 Profit

MT Newswires Live

昨天

Shanghai Haohai Biological Technology (HKG:6826) said it expects a 40% year-on-year drop in its 2025 profit based on a preliminary estimate, according to a Hong Kong bourse filing Friday.

The firm posted 251 million yuan in attributable profit for the year, compared with 420.4 million yuan in 2024, according to the preliminary figures.

Basic earnings per share were 1.08 yuan, compared with 1.80 yuan in 2024.

Revenue fell 8% year-on-year to 2.47 billion yuan, the firm said, citing the preliminary data.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2616006802"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2616006802\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2616006802?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-02 13:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616006802","market":"sg","top_or_hot":-1,"title":"Haohai Biological Says Preliminary Figures Show Drop in 2025 Profit","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SHBTF\">Shanghai Haohai Biological</a> Technology (HKG:6826) said it expects a 40% year-on-year drop in its 2025 profit based on a preliminary estimate, according to a Hong Kong bourse filing Friday.</p><p>The firm posted 251 million yuan in attributable profit for the year, compared with 420.4 million yuan in 2024, according to the preliminary figures.</p><p>Basic earnings per share were 1.08 yuan, compared with 1.80 yuan in 2024.</p><p>Revenue fell 8% year-on-year to 2.47 billion yuan, the firm said, citing the preliminary data.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Haohai Biological Says Preliminary Figures Show Drop in 2025 Profit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHaohai Biological Says Preliminary Figures Show Drop in 2025 Profit\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-03-02 13:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SHBTF\">Shanghai Haohai Biological</a> Technology (HKG:6826) said it expects a 40% year-on-year drop in its 2025 profit based on a preliminary estimate, according to a Hong Kong bourse filing Friday.</p><p>The firm posted 251 million yuan in attributable profit for the year, compared with 420.4 million yuan in 2024, according to the preliminary figures.</p><p>Basic earnings per share were 1.08 yuan, compared with 1.80 yuan in 2024.</p><p>Revenue fell 8% year-on-year to 2.47 billion yuan, the firm said, citing the preliminary data.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06826","symbol_name":"昊海生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2616006802","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616006802","pubTimestamp":1772429654,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shanghai Haohai Biological Technology  said it expects a 40% year-on-year drop in its 2025 profit based on a preliminary estimate, according to a Hong Kong bourse filing Friday.The firm posted 251 million yuan in attributable profit for the year, compared with 420.4 million yuan in 2024, according to the preliminary figures.Basic earnings per share were 1.08 yuan, compared with 1.80 yuan in 2024.Revenue fell 8% year-on-year to 2.47 billion yuan, the firm said, citing the preliminary data.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06826":"昊海生物科技","BK1593":"医美概念股","BK1161":"生物科技"},"translate_title":"昊海生物称初步数据显示2025年利润下降","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06826":1},"content_text":"Shanghai Haohai Biological Technology (HKG:6826) said it expects a 40% year-on-year drop in its 2025 profit based on a preliminary estimate, according to a Hong Kong bourse filing Friday.The firm posted 251 million yuan in attributable profit for the year, compared with 420.4 million yuan in 2024, according to the preliminary figures.Basic earnings per share were 1.08 yuan, compared with 1.80 yuan in 2024.Revenue fell 8% year-on-year to 2.47 billion yuan, the firm said, citing the preliminary data.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}